141 related articles for article (PubMed ID: 31145391)
1. OUTCOMES OF VITRECTOMY IN TERSON SYNDROME: A Multicenter Canadian Perspective.
Nazarali S; Kherani I; Hurley B; Williams G; Fielden M; Adatia F; Kherani A
Retina; 2020 Jul; 40(7):1325-1330. PubMed ID: 31145391
[TBL] [Abstract][Full Text] [Related]
2. Visual Outcomes after Vitrectomy for Terson Syndrome Secondary to Traumatic Brain Injury.
Narayanan R; Taylor SC; Nayaka A; Deshpande R; St Aubin D; Hrisomalos FN; Hu J; Rajagopal R; Tewari A; Apte RS
Ophthalmology; 2017 Jan; 124(1):118-122. PubMed ID: 27817917
[TBL] [Abstract][Full Text] [Related]
3. Anatomical and functional outcomes following vitrectomy for dense vitreous hemorrhage related to Terson syndrome in children.
Sayman Muslubas I; Karacorlu M; Hocaoglu M; Ersoz MG; Arf S
Graefes Arch Clin Exp Ophthalmol; 2018 Mar; 256(3):503-510. PubMed ID: 29288413
[TBL] [Abstract][Full Text] [Related]
4. Outcome indicators for vitrectomy in Terson syndrome.
Garweg JG; Koerner F
Acta Ophthalmol; 2009 Mar; 87(2):222-6. PubMed ID: 18537934
[TBL] [Abstract][Full Text] [Related]
5. Referral delay and ocular surgical outcome in Terson syndrome.
Gnanaraj L; Tyagi AK; Cottrell DG; Fetherston TJ; Richardson J; Stannard KP; Inglesby DV
Retina; 2000; 20(4):374-7. PubMed ID: 10950415
[TBL] [Abstract][Full Text] [Related]
6. Terson syndrome. Results of vitrectomy and the significance of vitreous hemorrhage in patients with subarachnoid hemorrhage.
Kuhn F; Morris R; Witherspoon CD; Mester V
Ophthalmology; 1998 Mar; 105(3):472-7. PubMed ID: 9499778
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Factors and Long-term Surgical Outcomes for Exudative Age-related Macular Degeneration with Breakthrough Vitreous Hemorrhage.
Kim TY; Kang HG; Choi EY; Koh HJ; Kim SS; Lee JH; Kim M; Byeon SH; Lee CS
Korean J Ophthalmol; 2020 Aug; 34(4):281-289. PubMed ID: 32783420
[TBL] [Abstract][Full Text] [Related]
8. Terson Syndrome - Clinical Presentation, Management, and Visual Outcomes in a Tertiary Centre.
Lima-Fontes M; Leuzinger-Dias M; Rodrigues R; Barros-Pereira R; Falcão M; Fernandes V; Alves-Faria P; Falcão-Reis F; Rocha-Sousa A
Clin Ophthalmol; 2023; 17():351-359. PubMed ID: 36721665
[TBL] [Abstract][Full Text] [Related]
9. Tissue plasminogen activator-assisted vitrectomy for submacular hemorrhage due to age-related macular degeneration.
Gok M; Karabaş VL; Aslan MS; Kara Ö; Karaman S; Yenihayat F
Indian J Ophthalmol; 2017 Jun; 65(6):482-487. PubMed ID: 28643713
[TBL] [Abstract][Full Text] [Related]
10. Anatomic and functional outcome after 23-gauge vitrectomy, peeling, and intravitreal triamcinolone for idiopathic macular epiretinal membrane.
Konstantinidis L; Berguiga M; Beknazar E; Wolfensberger TJ
Retina; 2009 Sep; 29(8):1119-27. PubMed ID: 19734764
[TBL] [Abstract][Full Text] [Related]
11. Peripheral retinal cryotherapy for postvitrectomy diabetic vitreous hemorrhage in phakic eyes.
Neely KA; Scroggs MW; McCuen BW
Am J Ophthalmol; 1998 Jul; 126(1):82-90. PubMed ID: 9683153
[TBL] [Abstract][Full Text] [Related]
12. Surgical outcomes for vitrectomy in Eales' disease.
Shukla D; Kanungo S; Prasad NM; Kim R
Eye (Lond); 2008 Jul; 22(7):900-4. PubMed ID: 17401324
[TBL] [Abstract][Full Text] [Related]
13. Early Vitrectomy for Spontaneous, Fundus-Obscuring Vitreous Hemorrhage.
Melamud A; Pham H; Stoumbos Z
Am J Ophthalmol; 2015 Nov; 160(5):1073-1077.e1. PubMed ID: 26209230
[TBL] [Abstract][Full Text] [Related]
14. Role of Tamponade in Vitrectomy for Proliferative Diabetic Retinopathy with Vitreous Hemorrhage.
Balakrishnan D; Jain B; Nayaka A; Rani PK; Mukundaprasad V; Jalali S
Semin Ophthalmol; 2017; 32(4):488-491. PubMed ID: 27128601
[TBL] [Abstract][Full Text] [Related]
15. Clinical observations and considerations in the treatment of Terson syndrome using 23G vitrectomy.
Ju C; Li S; Huang C; Li Y; Kyungwan H; Zhou F; Li J
Int Ophthalmol; 2020 Sep; 40(9):2185-2190. PubMed ID: 32377886
[TBL] [Abstract][Full Text] [Related]
16. Incidence of retinal detachment and visual outcome in eyes presenting with posterior vitreous separation and dense fundus-obscuring vitreous hemorrhage.
Sarrafizadeh R; Hassan TS; Ruby AJ; Williams GA; Garretson BR; Capone A; Trese MT; Margherio RR
Ophthalmology; 2001 Dec; 108(12):2273-8. PubMed ID: 11733270
[TBL] [Abstract][Full Text] [Related]
17. [Terson syndrome--a contribution to the timing of operation for pars plana vitrectomy].
Augsten R; Königsdörffer E
Klin Monbl Augenheilkd; 2007 Aug; 224(8):674-7. PubMed ID: 17717786
[TBL] [Abstract][Full Text] [Related]
18. Surgical outcomes of vitrectomy for breakthrough vitreous hemorrhage in eyes with exudative age-related macular degeneration.
Iwase T; Baba T; Saito Y; Nizawa T; Yokouchi H; Kubota-Taniai M; Kitahashi M; Yamamoto S
Int Ophthalmol; 2021 May; 41(5):1835-1844. PubMed ID: 33611763
[TBL] [Abstract][Full Text] [Related]
19. [Vitrectomy in Terson syndrome. Report of 18 cases].
Körner F; Meier-Gibbons F
Klin Monbl Augenheilkd; 1992 May; 200(5):468-71. PubMed ID: 1614128
[TBL] [Abstract][Full Text] [Related]
20. Clinical features and visual prognostic indicators after vitrectomy for Terson syndrome.
Liu X; Yang L; Cai W; Gao L; Li Y
Eye (Lond); 2020 Apr; 34(4):650-656. PubMed ID: 31455901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
